03/29/2024 3:47 PM | ORIC Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/29/2024 3:15 PM | ORIC Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/11/2024 4:28 PM | ORIC Pharmaceuticals (Filer)
| Form S-3ASR | |
03/11/2024 3:20 PM | ORIC Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/11/2024 7:19 AM | FMR LLC (Filed by) ORIC Pharmaceuticals (Subject)
| Form SC 13G/A | |
03/08/2024 3:20 PM | Chacko Jacob (Reporting) ORIC Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:19 PM | EcoR1 Capital, LLC (Filed by) ORIC Pharmaceuticals (Subject)
| Form SC 13G/A | |
|
02/13/2024 5:43 PM | ALKEON CAPITAL MANAGEMENT LLC (Filed by) ORIC Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024 8:26 AM | ORIC Pharmaceuticals (Subject) Prosight Management, LP (Filed by)
| Form SC 13G/A | |
02/09/2024 8:28 AM | FMR LLC (Filed by) ORIC Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/08/2024 7:01 PM | Chacko Jacob (Reporting) ORIC Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/07/2024 4:09 PM | BlackRock Inc. (Filed by) ORIC Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/04/2024 11:15 PM | ORIC Pharmaceuticals (Filer)
| Form EFFECT | |
01/30/2024 11:12 AM | ORIC Pharmaceuticals (Filer)
| Form D Notice of Exempt Offering of Securities | |
01/29/2024 4:25 PM | BlackRock Inc. (Filed by) ORIC Pharmaceuticals (Subject)
| Form SC 13G | |
01/22/2024 8:01 AM | ORIC Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/09/2024 8:00 AM | ORIC Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/28/2023 11:15 PM | ORIC Pharmaceuticals (Filer)
| Form EFFECT | |
12/19/2023 6:40 PM | ORIC Pharmaceuticals (Issuer) Piscitelli Dominic (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 6:42 PM | Multani Pratik S (Reporting) ORIC Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 6:39 PM | Chacko Jacob (Reporting) ORIC Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2023 3:32 PM | ORIC Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
11/06/2023 3:20 PM | ORIC Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023 3:10 PM | ORIC Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/23/2023 3:07 PM | ORIC Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/11/2023 8:28 PM | Chacko Jacob (Reporting) ORIC Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/07/2023 3:15 PM | Nextech Crossover I GP S.a r.l. (Filed by) ORIC Pharmaceuticals (Subject)
| Form SC 13G | |
07/05/2023 2:27 PM | ORIC Pharmaceuticals (Filer)
| Form D Notice of Exempt Offering of Securities | |
06/28/2023 6:18 PM | Chacko Jacob (Reporting) ORIC Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2023 5:05 AM | ORIC Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/26/2023 5:25 PM | Chacko Jacob (Reporting) ORIC Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2023 3:21 PM | ORIC Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |